Transcatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinoma

Hepatitis Monthly
Kavous FirouzniaAmir Hossein Jalali

Abstract

Although transcatheter arterial chemoembolization (TACE) has been widely used as a palliative treatment for unresectable hepatocellular carcinoma (HCC), its actual efficacy and prognostic usefulness have not been clarified in past studies. The aim of the study is to investigate the efficacy, complications, and prognostic factors of the TACE in unresectable HCC patients. Thirty-two patients with unresectable HCC were treated with TACE. The procedure was performed with a combination of Lipiodol, doxorubicin, and cytomycin followed by gelatin-sponge particles embolization. CT-scan imaging and liver function tests (AST, ALT, ALP, BIL, and PT) were performed before and after the TACE. All patients were followed-up for 6-months. Of all patients, 1 and 11 patients respectively, exhibited a complete response (CR) and a partial response (PR) (response rate, CR+PR, 44%). Data have shown that tumor size, number of lesions and number of involved segments are significantly reduced after the TACE performance (P < 0.05). No significant clinical adverse effect was observed in patients after the intervention. Also, liver function tests including AST, ALT, ALP, BIL, and PT did not significantly differ before and after the intervention (P > 0.05)...Continue Reading

References

May 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L MondazziG Idèo
May 11, 1995·The New England Journal of Medicine·UNKNOWN Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
Jul 1, 1996·Annals of Surgery·T Lehnert, C Herfarth
May 1, 1996·Journal of Vascular and Interventional Radiology : JVIR·H NganW K Tso
Nov 1, 1996·Cardiovascular and Interventional Radiology·H J JaegerK D Mathias
Mar 11, 1999·The New England Journal of Medicine·H B El-Serag, A C Mason
Dec 25, 2002·Japanese Journal of Clinical Oncology·Masafumi IkedaRyoko Iwata
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josep M Llovet, Jordi Bruix
Oct 28, 2004·Gastroenterology·Jordi BruixJosep M Llovet
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Dec 24, 2005·Journal of Vascular and Interventional Radiology : JVIR·Christos S GeorgiadesJean-Francois H Geschwind
Apr 21, 2010·Annals of Surgical Oncology·Eleni Liapi, Jean-Francois H Geschwind
Feb 15, 2013·Iranian Journal of Radiology : a Quarterly Journal Published by the Iranian Radiological Society·Hossein GhanaatiMadjid Shakiba
Feb 15, 2013·Iranian Journal of Radiology : a Quarterly Journal Published by the Iranian Radiological Society·Benan CaglayanGulsen Sarac
Sep 21, 2013·Iranian Journal of Radiology : a Quarterly Journal Published by the Iranian Radiological Society·Raman RajeshAzad Jaisiram
Dec 19, 2013·Iranian Journal of Radiology : a Quarterly Journal Published by the Iranian Radiological Society·Emin CakmakciZeki Karpat
Apr 3, 2014·Iranian Red Crescent Medical Journal·Hossein GhanaatiMadjid Shakiba

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

Graph
SPSS
pad prism

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.